PL EN


Preferences help
enabled [disable] Abstract
Number of results
2018 | 99 | 181-192
Article title

Prevention of seizures after ischemic stroke: association between statin use and the risk of seizures

Content
Title variants
Languages of publication
EN
Abstracts
EN
More than 50 million people worldwide suffer from epilepsy. In approximately 50% cases of newly diagnosed patients over 60 years of age seizures are related to stroke. Post-stroke lesions in brain tissue may result in 7 fold increase risk of seizures compared to the general population. The most significant risk factors for post-stroke seizures (PSS) and post-stroke epilepsy (PSE) include stroke severity, intracerebral or subarachnoid hemorrhage and cortical involvement. Increased incidence of PSS was also observed in younger patients especially with previous early PSS occurrence. Statins (HMG-CoA reductase inhibitors) are a class of lipid-lowering medications characterized by neuroprotective and antiepileptic effects. The main result of the performed studies was significantly reduced risk of developing PSS associated with a post-stroke, but not pre-stroke statin use. Moderate to high doses of statin and early administration in acute phase of stroke potentiated the beneficial effects of the treatment. The evidences for the association between PSS prevention and statin treatment become more significant, however the most recent AHA/ASA recommendations do not include any medications in the PSS prophylaxis. This article summarizes the current knowledge about the prediction and prevention of PSS and PSE.
Discipline
Year
Volume
99
Pages
181-192
Physical description
References
  • [1] S. Saxena, S. Li, Defeating epilepsy: A global public health commitment. Epilepsia Open 2 (2017) 153-155.
  • [2] K.M. Fiest, K.M. Sauro, S.Wiebe, S.B. Patten, C. Kwon, J. Dykeman, T. Pringsheim, D.L. Lorenzetti, N. Jetté, Prevalence and incidence of epilepsy A systematic review and meta-analysis of international studies. Neurology 88 (2017) 296-303.
  • [3] H. Yang, G. Rajah, A. Guo, Y. Wang, Q. Wang, Pathogenesis of epileptic seizures and epilepsy after stroke. Neurological Research (2018) 1-7 doi: 10.1080/01616412.2018.1455014
  • [4] A.E. Merkle, G. Gialdini, M.P. Lerario, N.S. Parikh, N.A. Morris, B. Kummer, L. Dunn, M.E. Reznik, S.B. Murthy, B.B. Navi, Z.M. Grinspan, C. Iadecola, H. Kamel, Population-Based Assessment of the Long-Term Risk of Seizures in Survivors of Stroke. Stroke 49 (2018) DOI: 10.1161/STROKEAHA.117.020178.
  • [5] R.S. Fisher, C. Acevedo, A. Arzimanoglou, A. Bogacz, J.H. Cross, C.E. Elger, J. Engel Jr, L. Forsgren, J.A. French, M. Glynn, D.C. Hesdorffer, B.I. Lee, G.W. Mathern, S.L. Moshé, E. Perucca, I.E. Scheffer, T. Tomson, M. Watanabe, S. Wiebe, ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55 (2014) 475-82.
  • [6] T.S. Olsen, Post-stroke epilepsy. Current Atherosclerosis Reports 3 (2001) 340-344.
  • [7] T. Bryndziar, P. Sedova, N.M. Kramer, J. Mandrekar, R. Mikulik, R.D. Brown, J.P. Klaas, Seizures Following Ischemic Stroke: Frequency of Occurrence and Impact on Outcome in a Long-Term Population-Based Study, Journal of Stroke and Cerebrovascular Diseases 25 (2016) 150–156.
  • [8] E. Beghi, A. Carpio, L. Forsgren, D.C. Hesdorffer, K. Malmgren, J.W. Sander, T. Tomson, W.A. Hauser, Recommendation for a definition of acute symptomatic seizure. Epilepsia 51 (2010) 671-675.
  • [9] R.S. Fisher, J.H. Cross, J.A. French, N. Higurashi, E. Hirsch, F.E Jansen, L. Lagae, S.L. Moshé, J. Peltola, E. Roulet Perez, I.E. Scheffer, S.M. Zuberi, Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia 58 (2017) 522-530.
  • [10] T. Tanaka, M. Ihara, Post-stroke epilepsy. Neurochemistry International 107 (2017) 219-228.
  • [11] C. Zhang, X. Wang, Y. Wang, J.G. Zhang, W. Hu, M. Ge, K. Zhang, X. Shao, Risk factors for post-stroke seizures: a systematic review and meta-analysis. Epilepsy Research 108 (2014) 1806-1816.
  • [12] N.S. Graham, S. Crichton, M. Koutroumanidis, C.D. Wolfe, A.G Rudd, Incidence and associations of poststroke epilepsy: the prospective South London Stroke Register. Stroke 44 (2013) 605-611.
  • [13] G.J. Jungehulsing, P.U. Heuschmann, M. Holtkamp, S. Schwab, P.L. Kolominsky-Rabas, Incidence and predictors of post-stroke epilepsy. Acta Neurologica Scandinavica 127 (2013) 427–430.
  • [14] Z. Hundozi, A. Shala, D. Boshnjaku, S. Bytyqi, J. Rrustemi, M. Rama, F. Jashari, Hypertension on admission is associated with a lower risk of early seizures after stroke. Seizure 36 (2016) 40-43.
  • [15] H. Stefan. Epilepsy in the elderly: facts and challenges. Acta Neurologica Scandinavica 124 (2011) 223–237.
  • [16] F. Rosenow, H. M. Hamer, S. Knake, The epidemiology of convulsive and nonconvulsive status epilepticus. Epilepsia 48 (2007) 82–84.
  • [17] F. Brigo, F. Tezzon, R. Nardone, Late-onset seizures and risk of subsequent stroke: a systematic review. Epilepsy & Behavior 31 (2014) 9-12.
  • [18] R. Arntz, L. Rutten-Jacobs, N. Maaijwee, H. Schoonderwaldt, L. Dorresteijn, E. van Dijk, F.E. de Leeuw, Post-Stroke Epilepsy in Young Adults: A Long-Term Follow-Up Study. PLoS One 8 (2013) e55498.
  • [19] T. Tanaka, H. Yamagami, M. Ihara, R. Motoyama, K. Fukuma, T. Miyagi, K. Nishimura, K.Toyoda, K. Nagatsuka, Seizure Outcomes and Predictors of Recurrent Post-Stroke Seizure: A Retrospective Observational Cohort Study. PLoS One 10 (2015) e0136200.
  • [20] M. Galovic, N. Döhler, B. Erdélyi-Canavese, A. Felbecker, P. Siebel, J. Conrad, S. Evers, M. Winklehner, T.J. von Oertzen, H.P. Haring, A. Serafini, G. Gregoraci, M. Valente, F. Janes, G.L. Gigli, M.R. Keezer, J.S. Duncan, J.W. Sander, M.J. Koepp, B. Tettenborn, Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): a multivariable prediction model development and validation study. The Lancet Neurology 17 (2018) 143–152.
  • [21] Y. Xu, M.L. Hackett, J. Chalmers, R.I. Lindley, X. Wang, Q. Li, T. Robinson, H. Arima, P.M. Lavados, C.S. Anderson; ENCHANTED Study Group. Frequency, determinants, and effects of early seizures after thrombolysis for acute ischemic stroke: The ENCHANTED trial. Neurology Clinical Practice 7 (2017) 324-332.
  • [22] VAlvarez, A.O. Rossetti, V. Papavasileiou, P. Michel, Acute seizures in acute ischemic stroke: does thrombolysis have a role to play? Journal of Neurology 260 (2013) 55-61.
  • [23] S. Jung, K. Schindler, O. Findling, M.L. Mono, U. Fischer, J. Gralla, M. El-Koussy, A. Weck, A. Galimanis, C. Brekenfeld, G. Schroth, H.P. Mattle, M. Arnold, Adverse effect of early epileptic seizures in patients receiving endovascular therapy for acute stroke. Stroke 43 (2012) 1584-1590.
  • [24] J. De Reuck, G. Van Maele, Acute ischemic stroke treatment and the occurrence of seizures. Clinical Neurology and Neurosurgery 112 (2010) 328-331.
  • [25] C. Bentes, H. Martins, A.R. Peralta, C. Morgado, C. Casimiro, A.C Franco, A.C. Fonseca, R. Geraldes, P. Canhão, E.M.T Pinho, T. Paiva, J.M. Ferro. Epileptic manifestations in stroke patients treated with intravenous alteplase. European Journal of Neurology 24 (2017) 755-761.
  • [26] Bianchin, M., Brondani, R., de Almeida, A., Cherubini, P., de Oliveira, M., Mota, S., & Krammer, B. (2017). Seizures and epilepsy after thrombolysis for acute ischemic stroke: a cohort study. Journal of the Neurological Sciences 381, 86-87.
  • [27] Z. Chen, L. Churilov, Z. Chen, J. Naylor, M. Koome, B. Yan, P. Kwan, Association between implementation of a code stroke system and poststroke epilepsy. Neurology 90 (2018) e1126-e1133.
  • [28] D. Ní Chróinín, K. Asplund, S. Åsberg, E. Callaly, E. Cuadrado-Godia, E. Díez-Tejedor, M. Di Napoli, S.T. Engelter, K.L. Furie, S. Giannopoulos, A.M. Gotto Jr, N. Hannon, F. Jonsson, M.K. Kapral, J. Martí-Fàbregas, P. Martínez-Sánchez, H.J. Milionis, J. Montaner, A. Muscari, S. Pikija, J. Probstfield, N.S. Rost, A.G. Thrift, K. Vemmos, P.J. Kelly, Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials. Stroke 44 (2013) 448-456.
  • [29] M. Kesim, E. Yulug, M. Kadioglu, I. Erkoseoglu, D.A. Aykan, N.I. Kalyoncu, E. Yaris, The effect of simvastatin on picrotoxin-induced seizure in mice. Journal of Pakistan Medical Association 62 (2012) 1187-1191.
  • [30] H. Shafaroodi, L. Moezi, A. Fakhrzad, M. Hassanipour, M. Rezayat, A.R. Dehpour, The involvement of nitric oxide in the anti-seizure effect of acute atorvastatin treatment in mice. Neurological Research 34 (2012) 847-853.
  • [31] K. Moazzami, S. Emamzadeh-Fard, M. Shabani, Anticonvulsive effect of atorvastatin on pentylenetetrazole-induced seizures in mice: the role of nitric oxide pathway. Fundamental & Clinical Pharmacology 27 (2013) 387-392.
  • [32] L. Moezi, H. Shafaroodi, M. Hassanipour, A. Fakhrzad, S. Hassanpour, A.R. Dehpour, Chronic administration of atorvastatin induced anti-convulsant effects in mice: the role of nitric oxide. Epilepsy & Behavior 23 (2012) 399-404.
  • [33] A. Siniscalchi, S. Mintzer, Statins for poststroke seizures. The first antiepileptogenic agent? Neurology 85 (2015) 1–2.
  • [34] F.J. Lin, H.W. Lin, Y.F. Ho, Effect of Statin Intensity on the Risk of Epilepsy After Ischaemic Stroke: Real-World Evidence from Population-Based Health Claims. CNS Drugs 32 (2018) 367-376.
  • [35] M. Etminan, A. Samii, J.M. Brophy, Statin use and risk of epilepsy: a nested case-control study. Neurology 75 (2010) 1496-1500.
  • [36] H.W. Lin, Y.F. Ho, F.J. Lin, Statin Use Associated with Lower Risk of Epilepsy after Intracranial Hemorrhage: A Population-Based Cohort Study. Br J Clin Pharmacol (2018) doi: 10.1111/bcp.13626.
  • [37] J. Guo, J. Guo, J. Li, M. Zhou, F. Qin, S. Zhang, B. Wu, L. He, D. Zhou, Statin treatment reduces the risk of poststroke seizures. Neurology 85 (2015) 701-707.
  • [38] A. Sierra-Marcos, V. Alvarez, M. Faouzi, B. Burnand, A.O. Rossetti, Statins are associated with decreased mortality risk after status epilepticus. European Journal of Neurology 22 (2015) 402-405.
  • [39] X. Rong, J. Yin, H. Wang, X. Zhang, Y. Peng, Statin treatment may lower the risk of postradiation epilepsy in patients with nasopharyngeal carcinoma. Epilepsia 58 (2017) 2172-2177.
  • [40] M.J. Pugh, J.E. Knoefel, E.M. Mortensen, M.E. Amuan, D.R. Berlowitz, A.C. Van Cott, New-onset epilepsy risk factors in older veterans. Journal of the American Geriatrics Society Soc 57 (2009) 237-242.
  • [41] L.U. Trivedi, C.A. Alvarez, I.A. Mansi, Association of Statin Therapy With Risk of Epilepsy in 2 Propensity Score-Matched Cohorts. Annals of Pharmacotherapy 52 (2018) 546-553.
  • [42] E. Russo, E. Donato di Paola, P. Gareri, A. Siniscalchi, A. Labate, L. Gallelli, R. Citraro, G. De Sarro. Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice. Pharmacological Research 70 (2013) 1-12.
  • [43] A. Pitkänen, R. Roivainen, K. Lukasiuk, Development of epilepsy after ischaemic stroke. The Lancet Neurology 15 (2016) 185-197.
  • [44] W.J. Powers, A.A. Rabinstein, T. Ackerson, O. M. Adeoye, N.C. Bambakidis, K. Becker, J. Biller, M. Brown, B.M. Demaerschalk, B. Hoh, E.C. Jauch, C.S. Kidwell, T.M. Leslie-Mazwi, B. Ovbiagele, P.A. Scott, K.N. Sheth, A.M. Southerland, D.V. Summers, D.L. Tirschwell. American Heart Association Stroke Council, 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 49 (2018) e46-e110.
Document Type
article
Publication order reference
YADDA identifier
bwmeta1.element.psjd-2b483cb8-1ca3-42bb-b3b9-b8ff04d3078c
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.